Key terms
About NTBL
Notable Labs Ltd. engages in the development of predictive medicines for patients with cancer. The company was founded in June 2014 and is headquartered in Foster City, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NTBL news
May 06
4:43pm ET
Notable Labs Shares Strategic Insights in Business Overview
Apr 15
8:01am ET
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Notable Labs (NTBL)
Apr 15
7:42am ET
Notable Labs price target lowered to $7 from $9 at Chardan
Apr 15
12:35am ET
Buy Rating for Notable Labs: Financial Stability and Strategic Advances in AML Clinical Trials
Apr 13
2:00am ET
Smaller Reporting Status for Notable Labs: Navigating Investor Concerns Amidst Scaled-Down Disclosure
Apr 12
8:07am ET
Notable Labs sees cash runway into 4Q24
Apr 12
8:06am ET
Notable Labs reports 2023 EPS ($3.41) vs. ($21.97) last year
Mar 25
8:31am ET
Two new option listings and option delistings on March 25th
Feb 23
12:16am ET
Buy Rating Affirmed for Notable Labs on Strategic Clinical Advancements and Promising PPMP Platform
Feb 22
8:34am ET
Notable Labs Advances Phase 2 Trial for Volasertib
Feb 22
8:22am ET
Notable Labs advances volasertib Phase 2 program
No recent press releases are available for NTBL
NTBL Financials
Key terms
Ad Feedback
NTBL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NTBL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range